Evaluation of the ASPYRE-Lung targeted variant panel: a rapid, low-input solution for non-small cell lung cancer biomarker testing and experience from three independent sites.
Herlihy SE, Gentile C, Scott SJ, Smith BA, Stoll KA, Schilter KF, Mordaka JM, Palmer RN, Xyrafaki C, Gillon-Zhang E, King C, Evans RT, Green AS, Silva AL, Stolarek-Januszkiewicz M, von Bargen K, Turner I, Ho CH, Collazos A, Potts ND, Nugent D, Jose J, Gray ER, Shapiro E, Levin WJ, Cooke A, Balmforth BW, Osborne RJ, Reddi HV, Van Deerlin VM.
Herlihy SE, et al. Among authors: king c.
Transl Lung Cancer Res. 2024 Nov 30;13(11):3083-3095. doi: 10.21037/tlcr-24-525. Epub 2024 Nov 28.
Transl Lung Cancer Res. 2024.
PMID: 39670005
Free PMC article.